Agger Mette Kirstine 4
4 · Lexeo Therapeutics, Inc. · Filed Jun 27, 2024
Insider Transaction Report
Form 4
Agger Mette Kirstine
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-25+18,000→ 18,000 totalExercise: $16.87Exp: 2034-06-24→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 25, 2025, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date.